Literature DB >> 17124622

Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin.

H Kilicarslan1, S Ayan, H Vuruskan, G Gokce, E Y Gultekin.   

Abstract

Detrusor sphincter dyssynergia (DSD) is an involuntary contraction of the external urethral sphincter during detrusor contraction. A high proportion of patients needing repeat surgery and long term failure have both been described in the literature. In the present study, we evaluated clinical characteristics, underlying disorders and outcomes of conservative medical treatment in 21 female patients. Two patients were newly diagnosed multiple sclerosis. Urodynamic studies were performed in all symptomatic patients, and consisted of measurement of post-micturition residuals, urethral pressure profilometry and EMG cystometry according to the criteria of the International Continence Society. All patients were treated with baclofen 15 mg/day and doxazosin 4 mg/day. Seven patients received tolterodine 4 mg/day in addition to baclofen and doxazocin because they had detrusor hyperreflexia (DH). In conclusion, treatment with either combined baclofen and doxazosin or anticholinergic agent tolterodine appeared to be effective. In addition, it should be kept in mind that DSD could be the first sign to any neurologic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17124622     DOI: 10.1007/s11255-006-0071-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  25 in total

Review 1.  Evaluation of female lower urinary tract symptoms: overview and update.

Authors:  D Gordon; A Groutz
Journal:  Curr Opin Obstet Gynecol       Date:  2001-10       Impact factor: 1.927

Review 2.  Advances in the molecular understanding of GABA(B) receptors.

Authors:  A Billinton; A O Ige; J P Bolam; J H White; F H Marshall; P C Emson
Journal:  Trends Neurosci       Date:  2001-05       Impact factor: 13.837

3.  Relative bladder outlet obstruction.

Authors:  Ries Kranse; Ron van Mastrigt
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450

4.  Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients.

Authors:  D D Dykstra; A A Sidi; A B Scott; J M Pagel; G D Goldish
Journal:  J Urol       Date:  1988-05       Impact factor: 7.450

5.  Videourodynamic study for diagnosis of bladder outlet obstruction in women.

Authors:  H C Kuo
Journal:  J Formos Med Assoc       Date:  2000-05       Impact factor: 3.282

6.  A double-blind trial with the antispasticity drug Lioresal in 15 paraplegics with upper neuron lesions.

Authors:  K Haubensak
Journal:  Urol Int       Date:  1977       Impact factor: 2.089

7.  Detrusor-urethral sphincter dyssynergia.

Authors:  S V Yalla; K J Blunt; B A Fam; N L Constantinople; R F Gittes
Journal:  J Urol       Date:  1977-12       Impact factor: 7.450

8.  Baclofen in the treatment of detrusor-sphincter dyssynergia in spinal cord injury patients.

Authors:  J F Leyson; B F Martin; A Sporer
Journal:  J Urol       Date:  1980-07       Impact factor: 7.450

9.  External urethral sphincterotomy: long-term follow-up.

Authors:  C C Yang; M E Mayo
Journal:  Neurourol Urodyn       Date:  1995       Impact factor: 2.696

10.  Sphincterotomy: long-term complications and warning signs.

Authors:  S Juma; M Mostafavi; A Joseph
Journal:  Neurourol Urodyn       Date:  1995       Impact factor: 2.696

View more
  2 in total

Review 1.  Autonomic Dysregulation in Multiple Sclerosis.

Authors:  Alexandra Pintér; Domonkos Cseh; Adrienn Sárközi; Ben M Illigens; Timo Siepmann
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

2.  Effects of Dietary Vitamin E Supplementation in Bladder Function and Spasticity during Spinal Cord Injury.

Authors:  Kathia Cordero; Gemma G Coronel; Miguel Serrano-Illán; Jennifer Cruz-Bracero; Johnny D Figueroa; Marino De León
Journal:  Brain Sci       Date:  2018-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.